TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) has issued an update.
Dawnrays Pharmaceutical Holdings Ltd. has announced the appointment of Mr. Hu Shuo as a non-executive director, effective August 1, 2025. Mr. Hu brings over 20 years of experience in equity investment and mergers and acquisitions, which could enhance the company’s strategic capabilities and strengthen its market position. His appointment is part of the company’s ongoing efforts to bolster its governance and leadership structure.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,157,732
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
For a thorough assessment of 2348 stock, go to TipRanks’ Stock Analysis page.